Walleye Capital’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $640K | Buy |
+4,218
| New | +$640K | ﹤0.01% | 987 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1922 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 2189 |
|
|
2024
Q3 | – | Sell |
-63,913
| Closed | -$13.2M | – | 2555 |
|
|
2024
Q2 | $13.2M | Buy |
63,913
+63,778
| +47,243% | +$13.2M | 0.02% | 197 |
|
|
2024
Q1 | $36.6K | Buy |
+135
| New | +$36.6K | ﹤0.01% | 2167 |
|
|
2023
Q4 | – | Sell |
-8,561
| Closed | -$1.68M | – | 2327 |
|
|
2023
Q3 | $1.68M | Buy |
+8,561
| New | +$1.68M | ﹤0.01% | 715 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2227 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2242 |
|
|
2022
Q4 | – | Sell |
-28,386
| Closed | -$5.59M | – | 2222 |
|
|
2022
Q3 | $5.59M | Buy |
28,386
+11,427
| +67% | +$2.25M | 0.11% | 197 |
|
|
2022
Q2 | $3.63M | Sell |
16,959
-27,364
| -62% | -$5.86M | 0.1% | 223 |
|
|
2022
Q1 | $12.6M | Buy |
44,323
+13,642
| +44% | +$3.87M | 0.34% | 47 |
|
|
2021
Q4 | $11.6M | Buy |
30,681
+29,744
| +3,174% | +$11.2M | 0.36% | 49 |
|
|
2021
Q3 | $387 | Buy |
+937
| New | +$387 | 0.01% | 875 |
|
|
2020
Q1 | – | Sell |
-1,140
| Closed | -$175K | – | 609 |
|
|
2019
Q4 | $175K | Buy |
1,140
+1,090
| +2,180% | +$167K | 0.01% | 391 |
|
|
2019
Q3 | $7K | Hold |
50
| – | – | ﹤0.01% | 441 |
|
|
2019
Q2 | $7K | Sell |
50
-1,342
| -96% | -$188K | ﹤0.01% | 442 |
|
|
2019
Q1 | $202K | Buy |
+1,392
| New | +$202K | 0.03% | 77 |
|